Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 21;11(2):e0490022.
doi: 10.1128/spectrum.04900-22. Online ahead of print.

Antibodies to Nucleocapsid Are Not Diagnostic for Long COVID

C T Brandt  1 , L Wiese  1 , K M Christiansen  2 , J Agergaard  3
Affiliations

Antibodies to Nucleocapsid Are Not Diagnostic for Long COVID

C T Brandt et al. Microbiol Spectr. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

  • [S1 guidelines for the management of postviral conditions using the example of post-COVID-19].
    Rabady S, Hoffmann K, Aigner M, Altenberger J, Brose M, Costa U, Denk-Linnert DM, Gruber S, Götzinger F, Helbok R, Hüfner K, Koczulla R, Kurz K, Lamprecht B, Leis S, Löffler J, Müller CA, Rittmannsberger H, Rommer PS, Sator P, Strenger V, Struhal W, Untersmayr E, Vonbank K, Wancata J, Weber T, Wendler M, Zwick RH. Rabady S, et al. Wien Klin Wochenschr. 2023 Jul;135(Suppl 4):525-598. doi: 10.1007/s00508-023-02242-z. Epub 2023 Aug 9. Wien Klin Wochenschr. 2023. PMID: 37555900 Free PMC article. German.

References

    1. Fogh K, Larsen TG, Hansen CB, Hasselbalch RB, Eriksen ARR, Bundgaard H, Frikke-Schmidt R, Hilsted LM, Østergaard L, Johansen IS, Hageman I, Garred P, Iversen K. 2022. Self-reported long COVID and its association with the presence of SARS-CoV-2 antibodies in a Danish cohort up to 12 months after infection. Microbiol Spectr 10:e02537-22. doi:10.1128/spectrum.02537-22. - DOI - PMC - PubMed
    1. van den Hoogen LL, Smits G, van Hagen CCE, Wong D, Vos ERA, van Boven M, de Melker HE, van Vliet J, Kuijer M, Woudstra L, Wijmenga-Monsuur AJ, GeurtsvanKessel CH, Stoof SP, Reukers D, Wijsman LA, Meijer A, Reusken CBEM, Rots NY, van der Klis FRM, van Binnendijk RS, den Hartog G. 2022. Seropositivity to nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: a complementary tool to detect breakthrough infections after COVID-19 vaccination? Vaccine 40:2251–2257. doi:10.1016/j.vaccine.2022.03.009. - DOI - PMC - PubMed
    1. Alfego D, Sullivan A, Poirier B, Williams J, Adcock D, Letovsky S. 2021. A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States. EClinicalMedicine 36:100902. doi:10.1016/j.eclinm.2021.100902. - DOI - PMC - PubMed

LinkOut - more resources